Trial NCT03919799

View at ClinicalTrials.gov 
Org. Study IDs: EFC17665
Secondary IDs: KD025-209

Last trial update was posted on 2023-08-30

MeSH Interventions

Belumosudil

MeSH Conditions

Scleroderma, Diffuse Scleroderma, Systemic Sclerosis

Other Conditions

Diffuse Cutaneous Systemic Sclerosis System; Sclerosis

Stopping Reasons

Sponsor decision due to slow enrollment and strategic consideration; not driven by any safety concerns.

Limitations And Caveats

The study was terminated early by the Sponsor due to slow enrollment and strategic consideration and was not driven due to any safety concerns.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID